Open Access
J Extra Corpor Technol
Volume 52, Number 4, December 2020
Page(s) 279 - 288
Published online 15 December 2020
  1. Fan Y, Zhang AM, Xiao YB, et al. Warm versus cold cardioplegia for heart surgery: A meta-analysis. Eur J Cardio Thorac Surg. 2010;37:912–9. [CrossRef] [Google Scholar]
  2. Guru V, Omura J, Alghamdi AA, et al. Is blood superior to crystalloid cardioplegia? A meta-analysis of randomized clinical trials. Circulation. 2006;114:I331–I338. [CrossRef] [PubMed] [Google Scholar]
  3. Braathen B, Tønnessen T Cold blood cardioplegia reduces the increase in cardiac enzyme levels compared with cold crystalloid cardioplegia in patients undergoing aortic valve replacement for isolated aortic stenosis. J Thorac Cardiovasc Surg. 2010;139:874–80. [CrossRef] [PubMed] [Google Scholar]
  4. Durandy YD Is there a rationale for short cardioplegia redosing intervals? World J Cardiol. 2015;7:658–64. [CrossRef] [PubMed] [Google Scholar]
  5. Drescher C, Diestel A, Wollersheim S, et al. How does hypothermia protect cardiomyocytes during cardioplegic ischemia? Eur J Cardio Thorac Surg. 2011;40:352. [Google Scholar]
  6. Mosmann T Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55–63. [CrossRef] [PubMed] [Google Scholar]
  7. Ciapetti G, Granchi D, Savarino L, et al. In vitro testing of the potential for orthopedic bone cements to cause apoptosis of osteoblast-like cells. Biomaterials. 2002;23:617–27. [CrossRef] [PubMed] [Google Scholar]
  8. Abdel Wahab SI, Abdul AB, Alzubairi AS, et al. In vitro ultramorphological assessment of apoptosis induced by zerumbone on (HeLa). J Biomed Biotechnol. 2009;2009:769568. [Google Scholar]
  9. Tan G, Kaya M, Tevlek A, et al. Antitumor activity of chitosan from mayfly with comparison to commercially available low, medium, and high molecular weight chitosans. In Vitro Cell Dev Biol-Animal. 2018;54:366–74. [CrossRef] [PubMed] [Google Scholar]
  10. Lazar HL Del Nido cardioplegia: Passing fad or here to stay? J Thorac Cardiovasc Surg. 2018;155:1009–10. [CrossRef] [PubMed] [Google Scholar]
  11. Guajardo Salinas GE, Nutt R, Rodriguez-Araujo G Del Nido cardioplegia in low-risk adults undergoing first-time coronary artery bypass surgery. Perfusion. 2017;32:68–73. [CrossRef] [PubMed] [Google Scholar]
  12. Gaudino M, Pragliola C, Anselmi A, et al. Randomized trial of HTK versus warm blood cardioplegia for right ventricular protection in mitral surgery. Scand Cardiovasc J. 2013;47:359–67. [CrossRef] [PubMed] [Google Scholar]
  13. Vistarini N, Laliberte E, Beauchamp P, et al. Del Nido cardioplegia in the setting of minimally invasive aortic valve surgery. Perfusion. 2017;32:112–7. [CrossRef] [PubMed] [Google Scholar]
  14. Hamad R, Nguyen A, Laliberte E, et al. Comparison of del Nido cardioplegia with blood cardioplegia in adult combined surgery. Innovations. 2017;12:356–62. [CrossRef] [PubMed] [Google Scholar]
  15. Li Y, Lin H, Zhao Y, et al. Del Nido cardioplegia for myocardial protection in adult cardiac surgery: A systematic review and meta-analysis. Am Soc Artif Intern Organs Trans. 2018;64:360–7. [CrossRef] [PubMed] [Google Scholar]
  16. Talwar S, Chatterjee S, Sreenivas V, et al. Comparison of del Nido and histidine-tryptophan-ketoglutarate cardioplegia solutions in pediatric patients undergoing open-heart surgery: A prospective randomized clinical trial. J Thorac Cardiovasc Surg. 2019;152:1182–93. [CrossRef] [PubMed] [Google Scholar]
  17. Ota T, Yerebakan H, Neely RC, et al. Short-term outcomes in adult cardiac surgery in the use of del Nido cardioplegia solution. Perfusion. 2016;31:27–33. [CrossRef] [PubMed] [Google Scholar]
  18. Kalogeris T, Baines CP, Krenz M, et al. Cell biology of ischemia/reperfusion injury. Int Rev Cell Mol Biol. 2012;298:229–317. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.